Current Strategies to Improve Erectile Function in Patients Undergoing Radical Prostatectomy – Intraoperative Scenario – Beyond the Abstract

Prostate cancer (CaP) is one of the tumors where cancer cells try to escape through perineural invasion thus complicating the task of nerve preservation, as both decision for, and technique of nerve-sparing could have an impact on outcomes. Due to competing goals, this is one procedure in which success is defined not just by achieving […]

Current Strategies to Improve Erectile Function in Patients Undergoing Radical Prostatectomy – Preoperative Scenario – Beyond the Abstract

Erectile dysfunction (ED) after radical prostatectomy (RP) has a complex pathophysiology and requires a transdisciplinary approach from the time of prostate cancer diagnosis. The understanding of patients’ cultural and psychosocial background, as well as their baseline health status and lifestyle before surgery, are fundamental to accomplish successful and personalized multilevel interventions. We have divided preoperative […]

VIDEO ID 2485 Transcript: Validating the Association of Adverse Pathology with Distant Metastasis and Prostate Cancer Mortality 20-Years After Radical Prostatectomy – Eric Klein

Alicia Morgans: Hi, my name is Alicia Morgans, and I’m a GU medical oncologist at Dana-Farber Cancer Institute. I am so excited to have here with me today Dr. Eric Klein, who is an emeritus professor at the Glickman Urological and Kidney Institute at Cleveland Clinic. Thank you so much for being here with me […]

VIDEO ID 2488 TRANSCRIPT: Validating the Association of Adverse Pathology with Distant Metastasis and Prostate Cancer – Michael Brooks

Alicia Morgans: Hi, my name is Alicia Morgans and I’m a GU Medical Oncologist at Dana-Farber Cancer Institute. I’m so pleased to have here with me today, Dr. Michael Brooks, who’s a Urologic Oncologist at Houston Methodist in Houston. Thank you so much for being here with me today. Michael Brooks: Thank you for inviting […]

UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients

–Investigator’s Retrospective Analysis Published in the Journal of Urology Provides Protocol for Antegrade Administration of Jelmyto, the only Non-Surgical, Kidney-Sparing Treatment for Adults with Low Grade Upper Tract Urothelial Cancer– Reno, Nevada (UroToday.com) — UroGen Pharma Ltd., a biotech company dedicated to creating novel solutions that treat urothelial and specialty cancers, announced the first published report of real-world experience […]

Retrograde intrarenal surgery: laser showdown (Ho:YAG vs thulium fiber laser).

Retrograde intrarenal surgery (RIRS) has always been recommended for large stones > 20 mm, using the Ho:YAG laser. The introduction of a new technology in the urological market, the thulium fiber laser (TFL) has revolutionized the endourology world because of its characteristics and significantly shorter laser-on time (LOT) and operative time, without scarifying the champ vision.

X